What WISAP does

WISAP Medical Technology GmbH is a privately held German medical device manufacturer founded in 1959 by Prof. Dr. Kurt Semm, one of the pioneers of modern laparoscopy. The company is headquartered in Brunnthal/Hofolding near Munich and operates as a specialist Mittelstand firm manufacturing exclusively in Germany. Its portfolio is organized around six core technology pillars for minimally invasive surgery: insufflation (Heatflow 50, Tetraflator, Flow-Therme), visualization (Auralis FHD camera system, FHD laparoscopes/hysteroscopes), irrigation (FlexiPump), morcellation (SafeCut hybrid in-bag system), thermocoagulation (C3 / C3 ECO4 for CIN 1-3 cervical lesion treatment), and reusable surgical instruments (PROLine). All products are developed and manufactured in Germany under EN ISO 13485:2016 certification with TÜV SÜD Product Service GmbH as the notified body and conform to EU Medical Device Directive 93/42/EWG.

The company's business model rests on three revenue streams: (i) direct hardware sales of devices and instruments to hospitals, clinics, and specialty departments performing gynecological and general laparoscopic procedures; (ii) OEM/PLM solutions providing custom or complementary minimally invasive surgery products to other medical device companies on a licensing/royalty basis; and (iii) technical service revenue through an RMA (Return Material Authorization) repair and maintenance process. Pricing is quote-based and not publicly disclosed, with sales handled via inquiry forms and direct sales representatives across multi-year contracts. The go-to-market combines a direct sales force for the DACH region (Germany, Austria, Switzerland) with a global network of distribution partners, supplemented by participation in major trade shows (Hospitalar in Latin America, Medica in Düsseldorf).

The company is led by Managing Director Stephan Hilgers (Geschäftsführer) under a traditional, privately held GmbH ownership structure with no disclosed institutional investors or external funding. Its operating footprint is documented across DACH and select international markets (Brazil being explicitly targeted via Hospitalar 2026), with leadership's stated intent to expand its distribution partner network, particularly into Latin America, while sustaining a full value-chain capability from R&D through regulatory clearance and global sales. Customer concentration is diffuse across the hospital, OEM/PLM, and distributor segments, with no named-anchor customers disclosed in the available material.

Name

WISAP

Legal name

WISAP® Medical Technology GmbH

Website

https://wisap.de

Company type

Private

Founded year

1959

Operating status

Operating

Headcount range

11–50 employees

Short description

WISAP Medical Technology GmbH is a privately held German manufacturer of minimally invasive surgery devices — insufflators, visualization systems, irrigation and morcellation systems, thermocoagulation units, and reusable instruments — founded in 1959 by laparoscopy pioneer Prof. Dr. Kurt Semm, serving hospitals, OEM partners, and distributors globally from its Brunnthal headquarters.

Ownership category

akta.pro rank

Product category

Medical Devices for Minimally Invasive Surgery

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)

akta.pro secondary industries

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Suction, Irrigation & Fluid Management Systems (HLAHADAK), Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC), Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

Keywords

• Minimally invasive surgery
• Laparoscopic instruments
• Insufflation systems
• Endoscopic imaging
• Gynecological surgery devices

Headquarters

HQ city

Brunnthal

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of medical devices and instruments for minimally invasive surgery including insufflators, visualization systems, irrigation systems, morcellation systems, thermocoagulation devices, and surgical instruments. Products are sold directly to hospitals and through distribution partners.
2. OEM/PLM Solutions: Custom product lifecycle management and OEM solutions for companies seeking complementary products in minimally invasive surgery or related niches.
3. Technical Service and Repairs: RMA (Return Material Authorization) service process for repairs and maintenance of devices and instruments.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

WISAP Medical Technology GmbH develops and manufactures medical devices and instruments for minimally invasive surgery, including warm gas insufflation systems, FHD visualization systems and endoscopes, irrigation systems, hybrid morcellation systems, thermocoagulation systems, and reusable surgical instruments. All products are manufactured exclusively in Germany for hospitals, specialty departments, OEM/PLM partners, and international distributors worldwide.

Product overview

WISAP Medical Technology GmbH develops and manufactures medical devices for minimally invasive surgery since 1959. The company offers a portfolio of core technologies including: Auralis FHD visualization systems and FHD laparoscopes/hysteroscopes for high-resolution imaging; Heatflow 50 and Tetraflator warm gas insufflators with Flow-Therme supplementary modules for gas insufflation and smoke evacuation; WISAP FlexiPump irrigation systems for precise fluid management; SafeCut hybrid morcellation systems for safe tissue removal; C3 and C3 ECO4 thermocoagulation systems for cervical lesion treatment; and PROLine multi-part reusable surgical instruments. These products form integrated system solutions designed for laparoscopic, hysteroscopic, and general surgical applications in clinics and hospitals worldwide. All products are manufactured exclusively in Germany.

Differentiator

Problem solved

Functional benefit

Brands

• Auralis: High-resolution imaging/camera system for endoscopy and laparoscopy
• Heatflow
• Tetraflator
• Flow-Therme
• SafeCut
• C3
• FlexiPump

Products and services

• Auralis FHD Visualization System Compact FHD camera system for endoscopy providing high-resolution imaging for laparoscopic and hysteroscopic procedures in hospitals and surgical departments.
• Heatflow 50 Warm Gas Insufflator
• Tetraflator Warm Gas Insufflator
• Flow-Therme Warm Gas Supplement Module
• SafeCut Hybrid Morcellation System
• C3 Thermocoagulation System
• FHD Laparoscopes and Hysteroscopes
• WISAP FlexiPump Irrigation System
• PROLine Surgical Instruments
• OEM/PLM Manufacturing Solutions

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Three partnerships are on record, tiered core and minor.

• TÜV SÜD Product Service GmbHcoreImplementation/ SI/ Consulting PartnerTÜV SÜD serves as the notified body for WISAP, ensuring continuous quality standards. This partnership is fundamental to WISAP's EN ISO 13485:2016 certification and compliance with Medical Device Directive 93/42/EWG.
• Hospitalar (Trade Show)minorGTM or Marketing PartnerWISAP participates in Hospitalar, Latin America's largest healthcare trade show, to meet potential distribution partners from the region.
• MEDICA (Trade Show)minorGTM or Marketing PartnerWISAP participates in MEDICA, one of the world's largest medical trade fairs with over 5,000 exhibitors from 72 nations and 80,000 visitors.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Erbe Elektromedizin: Erbe is a specialist in energy-based surgical devices (electrosurgery, thermofusion, plasma) and competes directly with WISAP's C3 thermocoagulation platform in gynecological and minimally invasive applications.
• Karl Storz: Karl Storz is the leading global specialist in endoscopes, visualization, and MIS instruments — directly competing with WISAP across laparoscopes, hysteroscopes, insufflators, and camera systems in gynecology and general surgery.
• Richard Wolf: Richard Wolf is a German-headquartered direct competitor in endoscopic surgery, offering rigid endoscopes, insufflators, irrigation, morcellation, and surgical instruments for gynecology, urology, and general MIS — overlapping almost one-to-one with WISAP's portfolio.

Broad incumbents

• Medtronic: Medtronic's Surgical Innovations business includes insufflators, energy devices, and surgical instruments competing with WISAP's portfolio across general and gynecological MIS, though Medtronic's broader portfolio makes it a broad incumbent rather than direct peer.
• Stryker: Stryker is a broad surgical-devices incumbent whose endoscopy, insufflation, and energy-based surgical lines directly overlap with several of WISAP's core product categories, particularly in gynecological laparoscopy.
• B. Braun Aesculap: B. Braun's Aesculap division manufactures surgical instruments, endoscopy systems, and OR equipment serving gynecology and general surgery, making it a broad incumbent peer in WISAP's core niches.
• ConMed: ConMed manufactures a broad portfolio of electrosurgical, insufflation, and visualization devices for minimally invasive gynecology and general surgery, with overlap on several of WISAP's energy, fluid management, and visualization products.
• Olympus Medical Systems: Olympus is a broad incumbent in endoscopy and surgical visualization, competing with WISAP's Auralis FHD camera system and FHD laparoscopes/hysteroscopes while offering a much larger integrated OR and service ecosystem.

Emerging players

• Lina Medical: Lina Medical is a niche player focused on hysteroscopy, morcellation, and uterine tissue removal systems, directly comparable to WISAP's SafeCut morcellation and hysteroscopy product lines.
• Gimmi: Gimmi is a smaller German endoscopy and surgical-instrument manufacturer with product overlap in rigid endoscopes, insufflators, and laparoscopic instruments aimed at gynecology and general surgery — directly comparable as a Mittelstand peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCfDE1xfAFGox3OnTbnMa0yg
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/wisap
• Xx.com/wisapgermany

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WISAP